These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease. Torres RJ; Puig JG Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316 [TBL] [Abstract][Full Text] [Related]
26. [Uric acid, a neglected molecule--the value of imaging]. Vock P; Bonel H Ther Umsch; 2004 Sep; 61(9):557-62. PubMed ID: 15493115 [TBL] [Abstract][Full Text] [Related]
27. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269 [TBL] [Abstract][Full Text] [Related]
28. The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics. Wu X; You C PeerJ; 2023; 11():e14554. PubMed ID: 36632144 [TBL] [Abstract][Full Text] [Related]
29. Gout and arrhythmias: In search for causation beyond association. Giannopoulos G; Angelidis C; Deftereos S Trends Cardiovasc Med; 2019 Jan; 29(1):41-47. PubMed ID: 29937218 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of hyperuricemia and gout]. Kamatani N Nihon Naika Gakkai Zasshi; 2007 Mar; 96(3):510-4. PubMed ID: 17419418 [No Abstract] [Full Text] [Related]
31. Why better treatment of gout is needed. So AK Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807 [TBL] [Abstract][Full Text] [Related]
32. [Definition and determination of serum uric acid level]. Nakajima H Nihon Rinsho; 2003 Jan; 61 Suppl 1():154-7. PubMed ID: 12629710 [No Abstract] [Full Text] [Related]
33. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549 [TBL] [Abstract][Full Text] [Related]
34. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts. Bakris GL; Doghramji PP; Keenan RT; Silber SH Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074 [TBL] [Abstract][Full Text] [Related]
35. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation]. Kolyvanos Naumann U; Suter PM; Käser L; Vetter W Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976 [No Abstract] [Full Text] [Related]
37. Gout and hyperuricemia: diagnosis and management. German DC; Holmes EW Hosp Pract (Off Ed); 1986 Nov; 21(11):119-26, 131-2. PubMed ID: 3095348 [No Abstract] [Full Text] [Related]
38. Management of hyperuricemia and gout in CKD. Gaffo AL; Saag KG Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014 [No Abstract] [Full Text] [Related]
39. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia. Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187 [TBL] [Abstract][Full Text] [Related]